Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Speyer

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cancer Investigation|January 1, 1989
Intraperitoneal cisplatin with i.v. therapyJ L Speyer
Seminars in Oncology|September 1, 1985
The rationale behind intraperitoneal chemotherapy in gastrointestinal malignanciesJ L Speyer
Seminars in Oncology|February 1, 1992
Intraperitoneal carboplatin: rationale and experienceJ L Speyer, J Sorich
The New England Journal of Medicine|February 27, 1999
Doxorubicin-induced cardiomyopathyF M Muggia, J L Speyer
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|May 21, 2005
Gain-scheduled controller for the suppression of convection at high Rayleigh numberA C Or, J L Speyer
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|May 23, 2006
Robust control for convection suppression in a fluid layer: The effects of boundary properties, actuator lag, and major parameter uncertaintiesA C Or, J L Speyer
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The use of peritoneal dialysis for delivery of chemotherapy to intraperitoneal malignanciesJ L Speyer, C E Myers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Can intraperitoneal chemotherapy alter the natural course of ovarian cancer?U Beller, E M Beckman, J L Speyer
Annals of Internal Medicine|November 1, 1985
Ovarian cancer: new therapeutic concepts, renewed optimismF M Muggia, M J Piccart, J L Speyer
European Journal of Cancer & Clinical Oncology|February 1, 1984
Cardiotoxicity of anthracyclinesM D Green, J L Speyer, F M Muggia
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cancer Investigation|January 1, 1989
Intraperitoneal cisplatin with i.v. therapyJ L Speyer
Seminars in Oncology|September 1, 1985
The rationale behind intraperitoneal chemotherapy in gastrointestinal malignanciesJ L Speyer
Seminars in Oncology|February 1, 1992
Intraperitoneal carboplatin: rationale and experienceJ L Speyer, J Sorich
The New England Journal of Medicine|February 27, 1999
Doxorubicin-induced cardiomyopathyF M Muggia, J L Speyer
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|May 21, 2005
Gain-scheduled controller for the suppression of convection at high Rayleigh numberA C Or, J L Speyer
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|May 23, 2006
Robust control for convection suppression in a fluid layer: The effects of boundary properties, actuator lag, and major parameter uncertaintiesA C Or, J L Speyer
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The use of peritoneal dialysis for delivery of chemotherapy to intraperitoneal malignanciesJ L Speyer, C E Myers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Can intraperitoneal chemotherapy alter the natural course of ovarian cancer?U Beller, E M Beckman, J L Speyer
Annals of Internal Medicine|November 1, 1985
Ovarian cancer: new therapeutic concepts, renewed optimismF M Muggia, M J Piccart, J L Speyer
European Journal of Cancer & Clinical Oncology|February 1, 1984
Cardiotoxicity of anthracyclinesM D Green, J L Speyer, F M Muggia
Pageof 6